Apposite Capital has sold its portfolio company Crest Optics to Evident, marking the fund's first exit from its Apposite Healthcare III fund. The Rome-based optical imaging systems developer saw revenues triple after Apposite invested in 2021, launching seven new products and digitally automating operations during ownership. Crest Optics designs and manufactures spinning disk confocal and structured illumination microscopy modules, including the X-Light family and CICERO systems.
The acquisition formalizes and expands an existing partnership, broadening Evident's life science imaging portfolio and enhancing capabilities in high-speed, 3D imaging for research, pharma, and biotech applications. Crest Optics will maintain its Rome headquarters and continue partner relationships. Primo Capital was also a previous investor.
Leerink advised financially, Chiomenti legally, Deloitte conducted due diligence, and Roland Berger performed commercial analysis.
Source: PE Hub · Résumé par HeadlinesBriefing